ArticleScientific reports2025
Mesenteric adipose tissue in Crohn's disease alters the immune response of the ileal mucosa and increases angiogenesis and fibrosis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mesenteric adipose tissue (MAT) may be involved in the pathogenesis of Crohn's disease (CD). However, its precise role remains uncertain. We analize the profile of molecules secreted by the MAT (secretome) in CD, differentiating between 'creeping fat' (CD-CrF) and the MAT obtained from a non-affected area (CD-NA), and to characterise its impact on the healthy ileum. The immune cell infiltration was higher in MAT from CD, particularly in CrF, compared to control-MAT. CD-NA and CD-CrF secretomes exhibited an increase of cytokines, immuno-checkpoints and other serum markers. A second profile included an increase in growth factors only in CD-CrF secretome. CD-NA and CD-CrF secretomes demonstrated enhanced myofibroblast wound healing and endothelial cell tube formation. On healthy human ileum, CD-NA and CD-CrF secretomes led to a down-regulation of genes related to antigen presentation to T cells, the major histocompatibility complex class II and the Th2 and Th17 cell differentiation. In conclusion, the profile of MAT secretome is different in CD patients, and their effects on the ileum, specially those of CrF, suggest a modification of the adaptive immune response, and a more pro-angiogenic and pro-fibrotic profile. MAT seems to have a significant role in the pathogenesis of CD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.